• Clinical Evidence

A Case Study: The Use of EndoTool in Obstetrics

Setting: 1,018-bed not-for-profit academic medical center and Level 1 trauma center.

Objective

This retrospective case study compares glycemic outcomes for labor and delivery patients before and after implementation of EndoTool (i.e., versus a paper protocol).

Setting

1,018-bed not-for-profit academic medical center and Level 1 trauma center.

Results

  • Incidence of hypoglycemia <70 mg/dL decreased 39.1% with EndoTool, from 4.6% to 2.8% of blood glucose readings.
  • Incidence of hypoglycemia <60 mg/dL decreased 42.9% with EndoTool, from 1.4% to 0.8% of blood glucose readings.
  • Average time to goal range of 70-100 mg/dL decreased 68.8% with EndoTool, from 12.5 to 3.9 hours.
  • Percentage of blood glucose measurements in the goal range increased 115.8% with EndoTool, from 19% to 41%.

Conclusions

Use of EndoTool for labor and delivery patients, including those with diabetes and DKA, provides markedly better glycemic outcomes than a paper protocol, as evidenced by lower incidence of hypoglycemia, significantly faster time to goal and a much higher percentage of blood glucose measurements in the goal range.
Objective

This retrospective case study compares glycemic outcomes for labor and delivery patients before and after implementation of EndoTool (i.e., versus a paper protocol).

Setting

1,018-bed not-for-profit academic medical center and Level 1 trauma center.

Results
  • Incidence of hypoglycemia <70 mg/dL decreased 39.1% with EndoTool, from 4.6% to 2.8% of blood glucose readings.
  • Incidence of hypoglycemia <60 mg/dL decreased 42.9% with EndoTool, from 1.4% to 0.8% of blood glucose readings.
  • Average time to goal range of 70-100 mg/dL decreased 68.8% with EndoTool, from 12.5 to 3.9 hours.
  • Percentage of blood glucose measurements in the goal range increased 115.8% with EndoTool, from 19% to 41%.
Conclusions

Use of EndoTool for labor and delivery patients, including those with diabetes and DKA, provides markedly better glycemic outcomes than a paper protocol, as evidenced by lower incidence of hypoglycemia, significantly faster time to goal and a much higher percentage of blood glucose measurements in the goal range.

References

Authors

Maresa Glass, PharmD, BCPS, BCCCP.

Source

Presented at EndoTool® User Group Meeting.

Year

2018

Quick navigation
Objective
Setting
Results
Conclusions
References
Objective

This retrospective case study compares glycemic outcomes for labor and delivery patients before and after implementation of EndoTool (i.e., versus a paper protocol).

Setting

1,018-bed not-for-profit academic medical center and Level 1 trauma center.

Results
  • Incidence of hypoglycemia <70 mg/dL decreased 39.1% with EndoTool, from 4.6% to 2.8% of blood glucose readings.
  • Incidence of hypoglycemia <60 mg/dL decreased 42.9% with EndoTool, from 1.4% to 0.8% of blood glucose readings.
  • Average time to goal range of 70-100 mg/dL decreased 68.8% with EndoTool, from 12.5 to 3.9 hours.
  • Percentage of blood glucose measurements in the goal range increased 115.8% with EndoTool, from 19% to 41%.
Conclusions

Use of EndoTool for labor and delivery patients, including those with diabetes and DKA, provides markedly better glycemic outcomes than a paper protocol, as evidenced by lower incidence of hypoglycemia, significantly faster time to goal and a much higher percentage of blood glucose measurements in the goal range.

References

Authors

Maresa Glass, PharmD, BCPS, BCCCP.

Source

Presented at EndoTool® User Group Meeting.

Year

2018

Short and Sweet Headlines are Best!

Related posts

Image
  • Clinical Evidence

Improving Inpatient Glycemic Safety at Temple Health with EndoTool SubQ

Improving Inpatient Glycemic Safety at Temple Health with EndoTool SubQ

Temple Health, a 3-hospital academic system was experiencing high rates of hypoglycemia due to reliance on sliding scale insulin (SSI). To improve safety and align with ADA guidelines, the hospital implemented EndoTool SubQ, a patient-specific insulin dosing software the supports four dosing protocols, including basal-bolus-correction (BBC).
Image
  • Clinical Evidence

How Corewell Health Reduced LOS for DKA Patients, Slashing Costs by Almost $1M

How Corewell Health Reduced LOS for DKA Patients, Slashing Costs by Almost $1M

The objective of this study was to evaluate the impact of EndoTool IV insulin dosing software on mortality, length of stay, readmission rates, and cost of care for patients treated for Diabetic Ketoacidosis (DKA) at Corewell Health West.
Image
  • Clinical Evidence

Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment

Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment

The objective of this study was to evaluate the impact of renal insufficiency on hypoglycemia rates in patients treated for Diabetic Ketoacidosis (DKA) utilizing a computerized insulin dosing algorithm.
Get in Touch

Ready to get started?

Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.